Abstract
We describe the effects of chronic droxidopa in a patient with Dopamine beta-hydroxylase deficiency diagnosed at the age of 73. Investigations were performed to assess sympathetic activity (MIBG scintigraphy, catecholamines) and cardiovascular droxidopa safety.
References
Senard JM, Rouet P (2006) Dopamine beta-hydroxylase deficiency. Orphanet J Rare Dis 1:7
Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2(8569):1170–1172
Courbon F, Brefel-Courbon C, Thalamas C et al (2003) Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson’s disease. Mov Disord 18(8):890–897
Kaufmann H, Saadia D, Voustianiouk A et al (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108(6):724–728
Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O (2009) Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Despas, F., Pathak, A., Berry, M. et al. DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa. Clin Auton Res 20, 205–207 (2010). https://doi.org/10.1007/s10286-009-0049-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-009-0049-7